Atezolizumab for adjuvant treatment of resected non-small-cell lung cancer [ID3852 ]
Proposed [GID-TA10751] Expected publication date: TBC
Search results
749 results
-
-
Lifileucel for previously treated unresectable or metastatic melanoma [ID3863]
Proposed [GID-TA10752] Expected publication date: TBC
-
Nivolumab for adjuvant treatment of high-risk hepatocellular carcinoma after liver resection or ablation [ID3858]
Proposed [GID-TA10745] Expected publication date: TBC
-
Pembrolizumab with chemotherapy then olaparib maintenance for treating BRCA-negative advanced epithelial ovarian, fallopian tube or peritoneal cancer [ID3853]
Proposed [GID-TA10747] Expected publication date: TBC
-
Treosulfan with fludarabine for non-malignant disease before allogeneic stem cell transplant [ID1540]
Proposed [GID-TA10453] Expected publication date: TBC
-
Dulaglutide for treating type 2 diabetes [ID1451]
Proposed [GID-TA10439] Expected publication date: TBC
-
Gosuranemab for treating progressive supranuclear palsy [ID1607]
Proposed [GID-TA10553] Expected publication date: TBC
-
Autologous haematopoietic stem cell transplantation for treating multiple sclerosis (ID1111)
Proposed [GID-TA10306] Expected publication date: TBC
-
Atezolizumab in combination for advanced epithelial ovarian, fallopian tube or primary peritoneal cancer in people who have not received any prior systemic therapy [ID2700]
Proposed [GID-TA10574] Expected publication date: TBC
-
Foslevodopa-foscarbidopa for treating Parkinson's disease with motor fluctuations [ID3876]
Proposed [GID-TA10772] Expected publication date: TBC
-
Gefapixant for treating refractory or unexplained chronic cough [ID3789]
Proposed [GID-TA10678] Expected publication date: TBC
-
Risankizumab for previously treated active psoriatic arthritis [ID1399]
Proposed [GID-TA10819] Expected publication date: TBC
-
Benralizumab for previously treated severe nasal polyps [ID1659]
Proposed [GID-TA10818] Expected publication date: TBC
-
Selumetinib for treating inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 years and over [ID1590]
Proposed [GID-TA10535] Expected publication date: TBC
-
Ibalizumab for treating adults infected with multidrug resistant HIV-1 for whom it is not possible to construct a suppressive anti-viral regimen [ID2720]
Proposed [GID-TA10657] Expected publication date: TBC
-
Finerenone for treating chronic kidney disease in people with type 2 diabetes [ID3773]
Proposed [GID-TA10820] Expected publication date: TBC
-
Avatrombopag in combination for treating chronic immune thrombocytopenia [ID3838]
Proposed [GID-TA10738] Expected publication date: TBC
-
Dapagliflozin for treating chronic kidney disease [ID3866]
Proposed [GID-TA10808] Expected publication date: TBC
-
Avatrombopag for treating chemotherapy-induced thrombocytopenia in non-haematological cancers [ID3837]
Proposed [GID-TA10737] Expected publication date: TBC
-
Burosumab for treating X-linked hypophosphataemia in adults [ID3822]
Proposed [GID-TA10733] Expected publication date: TBC
-
Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma after 1 systemic treatment [ID3869]
Proposed [GID-TA10757] Expected publication date: TBC
-
Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (CDF review of TA505) [ID1635]
Proposed [GID-TA10781] Expected publication date: 22 September 2021
-
Treprostinil for treating symptomatic chronic thromboembolic pulmonary hypertension [ID3926 ]
Proposed [GID-TA10821] Expected publication date: TBC
-
Burosumab for treating FGF23-related hypophosphataemia in tumour-induced osteomalacia [ID3924 ]
Proposed [GID-TA10822] Expected publication date: TBC
-
Inolimomab (Leukotac) for acute Graft versus host disease (aGvHD) after Allo-HSCT [ID3923]
Proposed [GID-TA10823] Expected publication date: TBC
-
Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy [ID3928]
Proposed [GID-TA10824] Expected publication date: TBC
-
Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver
In development [GID-IPG10177] Expected publication date: 21 April 2021
-
Electrohydraulic lithotripsy for difficult-to-treat bile duct stones
In development [GID-IPG10151] Expected publication date: 28 April 2021
-
Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults
In development [GID-IPG10143] Expected publication date: 28 April 2021
-
Transvenous obliteration of varices
In development [GID-IPG10206] Expected publication date: TBC
-
Image-guided cryoablation of peripheral neuroma for chronic pain
In development [GID-IPG10208] Expected publication date: TBC
-
Laparoscopic insertion of a magnetic titanium ring for gastro-oesophageal reflux disease
In development [GID-IPG10209] Expected publication date: TBC
-
Pharyngeal Electrical Stimulation for neurogenic dysphagia
In development [GID-IPG10212] Expected publication date: TBC
-
Trabeculectomy with biodegradable collagen matrix implant for glaucoma
In development [GID-IPG10211] Expected publication date: TBC
-
Percutaneous insertion of a closure device to repair a paravalvular leak around a replaced mitral or aortic valve
In development [GID-IPG10150] Expected publication date: 23 June 2021
-
Synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus)
In development [GID-IPG10161] Expected publication date: 23 June 2021
-
Endovascular forearm arteriovenous fistula creation for haemodialysis access
In development [GID-IPG10186] Expected publication date: TBC
-
Permanent His-bundle pacemaker implantation for heart failure
In development [GID-IPG10145] Expected publication date: 05 May 2021
-
High tibial osteotomy with adjustable magnetic nail insertion for symptomatic medial knee osteoarthritis
In development [GID-IPG10142] Expected publication date: TBC
-
Repetitive short- pulse transscleral cyclophotocoagulation for glaucoma
In development [GID-IPG10148] Expected publication date: TBC
-
Transapical transcatheter mitral valve-in-valve implantation for a failed surgically-implanted mitral valve bioprosthesis
In development [GID-IPG10152] Expected publication date: 28 July 2021
-
Transcatheter Mitral Valve In Ring (TMVIR) for treating a failing mitral valve repair
In development [GID-IPG10154] Expected publication date: 28 July 2021
-
Maintaining normothermia using temperature modulation devices to improve outcomes after stroke or subarachnoid haemorrhage
In development [GID-IPG10153] Expected publication date: 28 July 2021
-
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex - vivo lung perfusion) for transplantation
In development [GID-IPG10149] Expected publication date: 26 May 2021
-
Transvaginal laser therapy for urogenital atrophy
In development [GID-IPG10155] Expected publication date: 26 May 2021
-
Transvaginal laser therapy for stress urinary incontinence
In development [GID-IPG10156] Expected publication date: 26 May 2021
-
Laser lithotripsy for difficult-to-treat bile duct stones
In development [GID-IPG10157] Expected publication date: 26 May 2021
-
Microwave ablation for treating primary lung cancer and metastases in the lung
In development [GID-IPG10181] Expected publication date: TBC
-
Stereotactic radiosurgery for trigeminal neuralgia using the gamma knife
In development [GID-IPG10179] Expected publication date: TBC
-
Intramedullary distraction for lower limb lengthening
In development [GID-IPG10180] Expected publication date: TBC